Retinoblastoma (RB1) Pocket Domain Mutations and Promoter Hyper-methylation in Head and Neck Cancer

Overview

Journal Cell Oncol (Dordr)

Publisher Springer

Date 2014 Jun 4

PMID 24888624

Citations 11

Authors

Maimoona Sabir

Ruqia Mehmood Baig

Kashif Ali

Ishrat Mahjabeen

Muhammad Saeed

Mahmood Akhtar Kayani

Affiliations

Soon will be listed here.

Abstract

Background: The RB1 gene plays a pivotal role in cell cycle regulation. In this case-control study we searched for alterations in the RB1 pocket domain and its promoter region in head and neck cancer (HNC) patients in the Pakistani population.

Methods: For germline mutation analyses, 380 blood samples from HNC patients and 350 blood samples from control individuals were included. Polymerase chain reaction (PCR) and single strand conformational polymorphism (SSCP) assays, followed by sequence analyses, were used for the RB1 pocket domain mutation screens. For the RB1 promoter methylation screens, 72 HNC tumor samples along with adjacent uninvolved tissues were tested using a methylation-specific polymerase chain reaction (MSP) assay.

Results: RB1 (pocket domain and spacer region) sequence analysis revealed one frameshift and seven non-synonymous missense mutations. The frequency of missense mutations in exon 14, i.e., g76474C > T, g76475G > C and g76476A > G, resulting in Arg455Ser, was found to be highest (0.10). Missense mutations g76467G > C (exon14), g76468T > C (exon14), g77041A > T and g77043A > T (exon 16), when analyzed via Alamut biosoftware version 2.0, were found to be present in highly conserved amino acids with Align GVGD scores C15 (GV: 0.00-GD: 21.82), C65 (GV: 0.00-GD: 83.33) and C65 (GV: 0.00-GD: 98.69), respectively. These missense mutations were found to be deleterious by SIFT score: 0.00 (median 3.64). RB1 promoter methylation analysis revealed that 16% of its cytosines (3% in CpG) were methylated in the HNC tumor samples.

Conclusion: Our findings indicate that both genetic and epigenetic RB1 changes may contribute to the pathogenesis of HNC in the Pakistani population.

Citing Articles

Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms.

Shoaib S, Ansari M, Ghazwani M, Hani U, Jamous Y, Alali Z Cancers (Basel). 2023; 15(3).

PMID: 36765652 PMC: 9913804. DOI: 10.3390/cancers15030697.

Regulation of Canonical Oncogenic Signaling Pathways in Cancer via DNA Methylation.

Lu J, Wilfred P, Korbie D, Trau M Cancers (Basel). 2020; 12(11).

PMID: 33143142 PMC: 7692324. DOI: 10.3390/cancers12113199.

Genetic and expression variations of cell cycle pathway genes in brain tumor patients.

Naqvi A, Mahjabeen I, Ameen S, Ahmed M, Khan A, Akram Z Biosci Rep. 2020; 40(5).

PMID: 32373934 PMC: 7225413. DOI: 10.1042/BSR20190629.

Aberrant promoter methylation status is associated with upregulation of the E2F4 gene in breast cancer.

Farman F, Haq F, Muhammad N, Ali N, Rahman H, Saeed M Oncol Lett. 2018; 15(6):8461-8469.

PMID: 29805583 PMC: 5950537. DOI: 10.3892/ol.2018.8382.

Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma.

Tang J, Xie Y, Xu X, Yin Y, Jiang R, Deng L Cell Death Dis. 2017; 8(3):e2675.

PMID: 28300839 PMC: 5386573. DOI: 10.1038/cddis.2017.81.

References

Nakamura M, Watanabe T, Klangby U, Asker C, Wiman K, Yonekawa Y . p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol. 2001; 11(2):159-68. PMC: 8098332. DOI: 10.1111/j.1750-3639.2001.tb00388.x. View

Kornblau S, Chen N, Del Giglio A, OBrien S, Deisseroth A . Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res. 1994; 54(1):242-6. View

Claudio P, Howard C, Pacilio C, Cinti C, Romano G, Minimo C . Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res. 2000; 60(2):372-82. View

Simpson D, Hibberts N, McNicol A, Clayton R, Farrell W . Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res. 2000; 60(5):1211-6. View

Li A, Chia-Heng Li A, Tsay S, Li W, Liang W, Chen J . Alterations in the p16INK4a/cyclin D1/RB pathway in gastrointestinal tract endocrine tumors. Am J Clin Pathol. 2008; 130(4):535-42. DOI: 10.1309/TLLVXK9HVA89CHPE. View

Koontongkaew S, Chareonkitkajorn L, Chanvitan A, Leelakriangsak M, Amornphimoltham P . Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncol. 2000; 36(4):334-9. DOI: 10.1016/s1368-8375(99)00093-7. View

Shiboski C, Shiboski S, Silverman Jr S . Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol. 2000; 28(4):249-56. DOI: 10.1034/j.1600-0528.2000.280402.x. View

Taioli E, Ragin C, Wang X, Chen J, Langevin S, Brown A . Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer. 2009; 9:354. PMC: 2763008. DOI: 10.1186/1471-2407-9-354. View

Mayhew C, Carter S, Fox S, Sexton C, Reed C, Srinivasan S . RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology. 2007; 133(3):976-84. DOI: 10.1053/j.gastro.2007.06.025. View

10.

Ata-Ur-Rasheed M, Vemuganti G, Honavar S, Ahmed N, Hasnain S, Kannabiran C . Mutational analysis of the RB1 gene in Indian patients with retinoblastoma. Ophthalmic Genet. 2002; 23(2):121-8. DOI: 10.1076/opge.23.2.121.2211. View

11.

Das P, Singal R . DNA methylation and cancer. J Clin Oncol. 2004; 22(22):4632-42. DOI: 10.1200/JCO.2004.07.151. View

12.

Berge E, Knappskog S, Geisler S, Staalesen V, Pacal M, Borresen-Dale A . Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Mol Cancer. 2010; 9:173. PMC: 2908580. DOI: 10.1186/1476-4598-9-173. View

13.

Ha P, Califano J . Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol. 2006; 7(1):77-82. DOI: 10.1016/S1470-2045(05)70540-4. View

14.

Miyamoto H, Shuin T, Torigoe S, Iwasaki Y, Kubota Y . Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer. 1995; 71(4):831-5. PMC: 2033727. DOI: 10.1038/bjc.1995.160. View

15.

Masood N, Kayani M . Mutational analysis of xenobiotic metabolizing genes (CYP1A1 and GSTP1) in sporadic head and neck cancer patients. Genet Mol Biol. 2012; 34(4):533-8. PMC: 3229104. DOI: 10.1590/S1415-47572011005000034. View

16.

Smiraglia D, Smith L, Lang J, Rush L, Dai Z, Schuller D . Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet. 2003; 40(1):25-33. PMC: 1735270. DOI: 10.1136/jmg.40.1.25. View

17.

Gupta V, Schmidt A, Pashia M, Sunwoo J, Scholnick S . Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma. Int J Cancer. 1999; 84(5):453-7. DOI: 10.1002/(sici)1097-0215(19991022)84:5<453::aid-ijc1>3.0.co;2-f. View

18.

Gonzalez-Gomez P, Bello M, Alonso M, Arjona D, Lomas J, De Campos J . CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours. Br J Cancer. 2003; 88(1):109-14. PMC: 2376780. DOI: 10.1038/sj.bjc.6600737. View

19.

Blanquet V, Turleau C, Doz F, Besmond C . Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet. 1995; 4(3):383-8. DOI: 10.1093/hmg/4.3.383. View

20.

Rubin S, Gall A, Zheng N, Pavletich N . Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell. 2005; 123(6):1093-106. DOI: 10.1016/j.cell.2005.09.044. View